Anaxis Pharma

Company snapshot

Anaxis Pharma maintains 642 tracked programs across No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial with healthy volunteers., Melanoma, ulcerative colitis, Glioblastoma, Amyotrophic Lateral Sclerosis (ALS), Psoriatic Arthritis, Mantle Cell Lymphoma, Type 2 Diabetes Mellitus, ADHD, Parkinson's disease. Momentum score: n/a/100 (30-day delta: n/a).

• 147 approved product(s) across US/EU regulatory metadata.
• 642 active pipeline program(s) linked via ClinicalTrials.gov.
• 642 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Anaxis Pharma. Not investment advice.

• Peer + 0 momentum

  Disc Medicine

  TA overlap score 50

• Peer + 0 momentum

  Alaunos Therapeutics

  TA overlap score 26.8

Recent activity

Latest pipeline, patent, and corporate events for Anaxis Pharma.

1. Jun 8, 2026 Clinical update

   R2810-ONC-2045 — Phase 2

2. Jun 8, 2026 Clinical update

   NS229-P2-01 — Phase 2

3. Jun 8, 2026 Clinical update

   DCC-3116-01-001 — Phase 2

4. Jun 8, 2026 Clinical update

   BLCL-TOF-EU-01 — Phase 1

5. Jun 8, 2026 Clinical update

   BLCL-RUX-PIL01 — Phase 1

View all clinical trial activity →

• What is Anaxis Pharma?

  Lacuna Pharma Pty is a pharma organization headquartered in Colmenar Viejo, AU. Primary therapeutic focus areas include No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial with healthy volunteers., Melanoma, ulcerative colitis. Nov

• Is Anaxis Pharma publicly traded?

  Anaxis Pharma appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Anaxis Pharma develop or market?

  We link 673 drug profile(s) where Anaxis Pharma is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/pharma-mar-s-a#company-drugs.

• What are the latest developments for Anaxis Pharma?

  In the last 12 months our linked public records show 642 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Anaxis Pharma focus on?

  Anaxis Pharma focuses on No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial with healthy volunteers. based on our analysis of their pipeline programs and drug development activities.